Buy or sell Vineti stock pre IPO via an EquityZen fund
EquityZen is a marketplace for shares of proven pre IPO tech companies
Vineti Stock
Cell & Gene Therapy Software
About Vineti Stock
Vineti is a commercial cloud-based platform to expand patient access to life-saving cells and gene therapies. It is a software solution to drive and scale personalized therapeutic innovation. It solves the key challenges patients, medical providers, pharmaceutical companies, and regulators face in the delivery and commercialization of personalized medicine. Founded in 2016, Vineti is headquartered in San Francisco, California.
Investors
Canaan Partners
Instacart, Turo, The RealReal, Lending Club, Berkshire Grey, Apartment List, Kustomer, ON24, ShopKeep, PerimeterX
Cardinal Health
Casdin Capital
dRx Capital
HIVE Ventures
Kite Pharma
LifeForce Capital
HeartFlow, One Medical, Clover Health, Vineti, Verge Genomics
Section 32
Threshold
Zymergen, Remitly, Talkdesk, CircleCI, Yellowbrick Data, BetterUp, SugarCRM, Vineti, Doximity, Forward Networks
Funding History
| June 2017 | $13.8M |
|---|---|
| April 2018 | $33.5M |
| February 2020 | $35.0M |
Management
Chief Executive Officer
Amy DuRoss
Chief Technology Officer
Phil Calvin
Chief Strategy Officer
Louise Pacini
Press
Globe Newswire - Jun, 16 2020
Globe Newswire - Feb, 5 2020
Other Companies
EquityZen does not have an affiliation with, formal relationship with, or endorsement from Vineti or any companies feature above. This profile is based on publicly available information and is intended to be informative in nature.
Some data provided by Crunchbase
EquityZen Recognized As:
